Key Transaction Details
Mr. Yogesh Agrawal (Promoter Seller) of Genomic Valley Biotech Limited entered into a Share Purchase Agreement dated October 19, 2026 with Mr. Pankaj Grover and Mr. Abhisek Gupta (Acquirers). The agreement involves the sale of the promoter's entire shareholding in the company to the acquirers.
Quantitative Figures
The transaction involves the sale of 14,07,000 (Fourteen Lakhs Seven Thousand) equity shares, representing 46.06% (Forty Six Point Zero Six Percent) of the voting share capital of the company. Each share has a face value of ₹10.
Shareholding Details
Prior to the transaction:
- Yogesh Agrawal held 14,07,000 shares (46.06% of voting capital)
- Pankaj Grover held Nil shares
- Abhisek Gupta held Nil shares
Regulatory Impact
The transaction triggers an obligation on the acquirers to make an open offer to public shareholders under SEBI (Substantial Acquisitions of Shares and Takeovers) Regulations, 2011 (SAST Regulations).
Control and Management Impact
Upon completion of the open offer and proposed transaction, the acquirers will acquire and exercise control over the company and will be classified as promoters in accordance with Regulation 31A of SEBI (LODR) Regulations, 2015. The existing promoter directors will tender their resignation from the board of the company.
Relationship Disclosure
Except for the promoter seller, none of the parties to the SPA are related to promoter/promoter group/group companies in any manner. The transaction is not considered a related party transaction.
Additional Information
The disclosure is made pursuant to master circular reference number HO/49/14/14(7)2025- CFD-POD2/I/3762/2026 dated January 30, 2026. No financial restrictions or liabilities are imposed on the listed entity as per the agreement.
#Tags: #GenomicValleyBiotech #SharePurchaseAgreement #SEBIDisclosure #OpenOffer #ControlChange